Search research articles
Contact Us
Filters
Showing results (21-30 of 95) with videos related to
Page
of 10
Sort By:
World Journal of Gastroenterology
|
January 14, 2017
Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein
Francois Ghiringhelli, Corentin Richard, Sandy Chevrier, et al.
Journal for Immunotherapy of Cancer
|
October 27, 2023
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
Nicolas Roussot, Julie Lecuelle, Lorraine Dalens, et al.
Journal of Cancer Research and Clinical Oncology
|
June 1, 2020
Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France
Anne Aarnink, Jean David Fumet, Laure Favier, et al.
Journal of Gastrointestinal Oncology
|
September 17, 2021
Influence of first line chemotherapy strategy depending on primary tumor location in metastatic colorectal cancer
Zoé Tharin, Julie Blanc, Ikram Charifi Alaoui, et al.
Cancer Immunology, Immunotherapy : CII
|
March 16, 2022
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
Marion Thibaudin, Emeric Limagne, Léa Hampe, et al.
Molecular and Clinical Oncology
|
October 11, 2021
Utility of exome sequencing in routine care for metastatic colorectal cancer
Melchior De Giraud D'Agay, Loïck Galland, Zoe Tharin, et al.
World Journal of Gastroenterology
|
March 4, 2014
Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients
Laurie Rambach, Aurelie Bertaut, Julie Vincent, et al.
World Journal of Gastroenterology
|
February 27, 2015
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
Jean-Florian Guion-Dusserre, Veronique Lorgis, Julie Vincent, et al.
Anticancer Research
|
October 3, 2018
Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors
Thomas Collot, Jean-David Fumet, Quentin Klopfenstein, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2020
Immunological features of coronavirus disease 2019 in patients with cancer
Marion Thibaudin, Jean-David Fumet, Marjorie Bon, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 95) with videos related to
Sort By:
Page
of 10
World Journal of Gastroenterology
|
January 14, 2017
Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein
Francois Ghiringhelli, Corentin Richard, Sandy Chevrier, et al.
Journal for Immunotherapy of Cancer
|
October 27, 2023
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report
Nicolas Roussot, Julie Lecuelle, Lorraine Dalens, et al.
Journal of Cancer Research and Clinical Oncology
|
June 1, 2020
Role of pleural and peritoneal metastasis in immune checkpoint inhibitors efficacy patients with non-small cell lung cancer: real-world data from a large cohort in France
Anne Aarnink, Jean David Fumet, Laure Favier, et al.
Journal of Gastrointestinal Oncology
|
September 17, 2021
Influence of first line chemotherapy strategy depending on primary tumor location in metastatic colorectal cancer
Zoé Tharin, Julie Blanc, Ikram Charifi Alaoui, et al.
Cancer Immunology, Immunotherapy : CII
|
March 16, 2022
Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
Marion Thibaudin, Emeric Limagne, Léa Hampe, et al.
Molecular and Clinical Oncology
|
October 11, 2021
Utility of exome sequencing in routine care for metastatic colorectal cancer
Melchior De Giraud D'Agay, Loïck Galland, Zoe Tharin, et al.
World Journal of Gastroenterology
|
March 4, 2014
Prognostic value of chemotherapy-induced hematological toxicity in metastatic colorectal cancer patients
Laurie Rambach, Aurelie Bertaut, Julie Vincent, et al.
World Journal of Gastroenterology
|
February 27, 2015
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
Jean-Florian Guion-Dusserre, Veronique Lorgis, Julie Vincent, et al.
Anticancer Research
|
October 3, 2018
Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors
Thomas Collot, Jean-David Fumet, Quentin Klopfenstein, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2020
Immunological features of coronavirus disease 2019 in patients with cancer
Marion Thibaudin, Jean-David Fumet, Marjorie Bon, et al.
Page
of 10